- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00844350
The Effect of Oxytocin (OT) and Oxytocin Plus Human Chorionic Gonadotropin (hCG), in Cycles Induced by Letrozole or Clomiphene Citrate
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In a randomized controlled prospective clinical study, a total of 177 infertile women with CC+hCG-resistant PCOS included. The candidates were selected for this study in the clinics of Tabriz University of Medical Sciences, East Azarbayejan Province, North West of Iran, from Oct. 2006 to Sep. 2007. Infertile women who had chronic anovulation and classical PCOS with CC+hCG failure were age <40 y , had patent tubes on hysterosalpingography, and no other pelvic pathology, participated in this study. The patients who had hypersensivity to any oxytocic medications, history of cardiovascular disease, and took anti-hypertensive medications were excluded. In addition, women with blood pressure less than 90/60 mmHg, abnormal spermogram, anxiety, excess prolactin levels, and other causes of infertility were excluded. All participants were given adequate information, and consent was obtained from each participant.
The candidates were randomly divided into five groups including; letrozole + hCG (36 patients) (group 1), letrozole + OT (35 patients) (group 2), letrozole +OT + hCG (35 patients) (group 3), CC + OT (35 patients) (group 4), and CC + OT + hCG (36 patients) (group 5). Participants received letrozole 2.5mg at first month and 5mg at the second and third month. Also, CC was used 50 mg at the first month, to 150 mg at the third month to stimulate follicular growth. Oxytocin (OXYTIP; manufactured by IPDIC, Rasht, Iran), 5 IU and hCG (Choriomon; manufactured by IBSA Institute Biochimique SA, CH-6903 Lugano), 5000 IU were also administrated to induce ovulation. All patients underwent transvaginal sonography on day 13 to document the numbers of follicles and endometrial thickness. Participants were evaluated for three courses of intervention. Oxytocin was injected intramuscularly after CC or letrozol stimulation had induced enlarged ovarian follicles ( >18 mm in diameter to 30 mm). Decision to give a 5 IU dose of OT was made according to the pilot study (30). The patients who had larger follicles (more than 30mm in diameter), were withdrawn. The patients, who achieved pregnancy at the first or second month, were also withdrawn. All participants were evaluated for the levels of plasma progesterone one week after the injection of OT, hCG, or combination of them. A follow-up visit was arranged for each group every month at the second day of menstruation until 3 months after recruitment or at any time during the trial if pregnancy was achieved.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- infertile women who had chronic anovulation
- classical PCOS with CC+hCG failure
- age <40 y
- had patent tubes on hysterosalpingography
- no other pelvic pathology
- participated in this study
Exclusion Criteria:
- hypersensitivity to any oxytocic medications
- history of cardiovascular disease
- took anti-hypertensive medications were excluded.
- women with blood pressure less than 90/60 mmHg
- abnormal spermogram
- anxiety
- excess prolactin levels
- other causes of infertility were excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: letrozole+hCG
|
|
No Intervention: letrozole+oxytocin
|
|
No Intervention: letrozole+oxytocin+hCG
|
|
No Intervention: clomiphene citrate +oxytocin
|
|
No Intervention: clomiphene citrate +oxytocin+hCG
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
number of follicles, endometrial thickness, and clinical pregnancy rate
Time Frame: first ,second and third month
|
first ,second and third month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Antineoplastic Agents
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormone Antagonists
- Aromatase Inhibitors
- Steroid Synthesis Inhibitors
- Estrogen Antagonists
- Reproductive Control Agents
- Fertility Agents, Female
- Fertility Agents
- Selective Estrogen Receptor Modulators
- Estrogen Receptor Modulators
- Oxytocics
- Letrozole
- Oxytocin
- Clomiphene
- Enclomiphene
- Zuclomiphene
Other Study ID Numbers
- 8725
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ovarian Response
-
Barzilai Medical CenterRecruitingPoor Ovarian Response | Ovarian InsufficiencyIsrael
-
Andros Day Surgery ClinicCompleted
-
IVI MadridCompleted
-
Hospital Clinic of BarcelonaCompleted
-
Shi YunXiyuan Hospital, China Academy of Traditional Chinese MedicineRecruiting
-
Mỹ Đức HospitalCompletedPoor Ovarian ResponseVietnam
-
Nanjing UniversityRecruiting
-
ShangHai Ji Ai Genetics & IVF InstituteCompleted
-
Al Baraka Fertility HospitalUnknown
-
Shaanxi Hospital of Traditional Chinese MedicineNorthwest Women's and Children's Hospital, Xi'an, ShaanxiUnknown
Clinical Trials on letrozole , oxytocin,hCG,clomiphene citrate
-
The Egyptian IVF-ET CenterUnknown
-
New Hope Fertility CenterCompletedInfertilityUnited States
-
mostafa gomaa hamid halawaAin Shams Maternity HospitalUnknownPolycystic Ovary Syndrome | Anovulation
-
Cairo UniversityAhmed Elgazzar HospitalCompleted
-
Mohamed Sayed AbdelhafezCompletedInfertility | Polycystic Ovarian SyndromeEgypt
-
Cairo UniversityUnknown
-
Dinesh Khanna, MD, MSBayerCompletedScleroderma | Digital UlcersUnited States
-
Xiyuan Hospital of China Academy of Chinese Medical...Dongzhimen Hospital, Beijing; Beijing Hospital of Traditional Chinese Medicine and other collaboratorsUnknownPolycystic Ovarian Syndrome | Hyperprolactinemia | Anovulatory Infertility | Abnormal Uterine Bleeding-Ovulatory Disorders | Luteinized Unruptured Follicle Syndrome | Corpus Luteum Insufficiency | Ovarian Insufficiency
-
Services Institute of Medical Sciences, PakistanCompletedLetrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian SyndromePolycystic Ovary Syndrome | InfertilityPakistan